PharmaNeuroBoost NV - Product Pipeline Review - 2013 - New Study Released

Fast Market Research recommends "PharmaNeuroBoost NV - Product Pipeline Review - 2013" from Global Markets Direct, now available


Boston, MA -- (SBWire) -- 02/03/2014 --Global Market Direct's pharmaceuticals report, "PharmaNeuroBoost NV - Product Pipeline Review - 2013" provides data on the PharmaNeuroBoost NV's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, PharmaNeuroBoost NV's corporate website, SEC filings, investor presentations and featured press releases, both from PharmaNeuroBoost NV and industry-specific third party sources, put together by Global Markets Direct's team.


- PharmaNeuroBoost NV - Brief PharmaNeuroBoost NV overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of PharmaNeuroBoost NV human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of PharmaNeuroBoost NV with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the PharmaNeuroBoost NV's pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

View Full Report Details and Table of Contents

Reasons to Get This Report

- Evaluate PharmaNeuroBoost NV's strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of PharmaNeuroBoost NV in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the PharmaNeuroBoost NV's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with PharmaNeuroBoost NV.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of PharmaNeuroBoost NV and identify potential opportunities in those areas.

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Galapagos NV - Product Pipeline Review - 2013
- Ablynx NV - Product Pipeline Review - 2013
- ActogeniX NV - Product Pipeline Review - 2013
- ThromboGenics NV - Product Pipeline Review - 2013
- TiGenix NV - Product Pipeline Review - 2013
- Apitope International NV - Product Pipeline Review - 2013
- Amakem NV - Product Pipeline Review - 2013
- Diabetic Retinopathy - Pipeline Review, H2 2013
- Inflammatory Bowel Disease - Pipeline Review, H1 2013
- Clostridium Infections - Pipeline Review, H1 2013

Media Relations Contact

Bill Thompson
Director of Marketing

View this press release online at: